This inventor holds 1 USPTO granted patent. Top assignee: Genesen Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Kyuhyung Han: A Pioneer in Protein Transduction Innovations
Introduction
Kyuhyung Han is an innovative inventor based in Chuncheon-si, South Korea. With a notable patent to his name, he has made significant strides in the field of protein transduction, demonstrating a commitment to advancing medical science through innovative research and development.
Latest Patents
Han holds a patent titled "Protein transduction domain, fusion compound containing the same, and pharmaceutical composition containing the fusion compound." This invention proposes a more efficient protein transduction domain and fusion compound. After extensive testing of various candidate peptides, Han and his team discovered that a GK1 peptide, which consists of 18 amino acids, can effectively bond with high-molecular-weight materials such as proteins. This property allows these materials to penetrate living organisms, including cells, tissues, and blood, enhancing their potential for use in pharmaceutical compositions aimed at preventing or treating diseases.
Career Highlights
Currently, Kyuhyung Han is affiliated with Genesen Co., Ltd., where he applies his expertise in biotechnology and innovation. His work has contributed to the understanding and application of protein transduction domains, showcasing the potential for more effective drug delivery systems.
Collaborations
Throughout his career, Han has collaborated with talented colleagues, including Soo-Young Choi and Jin-Seu Park. These partnerships have been essential in the research and development of his patented technologies, highlighting the collaborative nature of scientific advancement.
Conclusion
Kyuhyung Han's contributions to the field of protein transduction represent an important step forward in medical biotechnology. His innovative patent demonstrates not only his ingenuity but also the potential for impactful applications in the treatment of various diseases. With continued research and collaboration, Han’s work may pave the way for future breakthroughs in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile